Topics
5 signals
CMS finalized a permanent framework for Medicare drug price negotiations, including selection of up to 20 additional Part D and/or Part B drugs by February 1, 2027, for prices effective in 2029. The rule creates compliance and planning implications for manufacturers, Medicare plans, and firms supporting drug pricing, formularies, benefits administration, and payment operations; it does not announce a procurement opportunity.
The Center for Civic Futures awarded $11 million to 11 projects using AI to improve benefits access and modernize state systems. The grants are already awarded, not an open solicitation, but point to potential follow-on needs in implementation, data integration, AI governance, and legacy-system modernization.
OPM identified about 50,000 deceased individuals still listed in FEHBP records, including $96.3 million in payments made after dates of death and an estimated $10.4 million in carrier costs. The review signals closer scrutiny of enrollment verification, payment controls, and claims processing, but does not announce a contract award or solicitation.
Milwaukee County's health insurance contract for 5,100 employees, dependents, and retirees lapsed in December under County Executive David Crowley. Coverage continued under the expired agreement until a replacement was approved in February, highlighting critical contract renewal and approval timeline vulnerabilities.
Discussion of the proposed 2027 MHBP Standard Plan points to GLP-1 coinsurance rising from 30% capped at $200 in 2026 to 50% with no stated cap. Final terms, the plan allowance, and eligibility remain unclear, making this a potential benefits-design change—not a confirmed procurement action or government-wide policy shift.